Romanian Pharmaceutical Sector -Between Challenges, Opportunities and Market Threats. . Legal Aspects of the Trading of Listed Companies
Abstract
Companies operating in the health and medical sciences will face this year not only with the challenges of an increasingly globalized market, but also with specific problems, both regional and national.
While other large sectors, such as the food industry, are poorly represented on the Romanian stock market, the pharmaceutical sector is represented by the following six companies: Antibiotics, Biofarm, FarmaceuticaRemedia, MedLife, Zentiva and Ropharma. During 2014-2016, these companies recorded oscillatory developments in sales and the net result of the year, as a result of the price reduction for drugs, the need for law to separate wholesale distribution from wholesale, a significant reduction in discounts to distributors, with an importan negative impact on their margin.
Globally, the pharmaceutical market is estimated to over $ 1 trillion,according the outcomes in 2016, while the top 15 companies accounting represent about 40% of the total.
References
[2] Law No. 297/2004 on capital market with subsequent amendments and completions.
[3] RNSC Regulation No. 1/2006 on issuers and transactions with securities with subsequent amendments and completions.
[4] EC Regulation 809/2004 on the implementation of Directive 2003/71 / EC as regards the information contained in prospectuses and the format, inclusion and publication of such prospectuses and dissemination of advertising material.
[5] website http://www.cnvmr.roon. Accessed at: 20.12.2017
[6] http://bvb.ro/FinancialInstruments/Details/FinancialInstrumentsDetails.aspx?s=SCD, Accessed at: 12.12.2017
[7] http://bvb.ro/FinancialInstruments/Details/FinancialInstrumentsDetails.aspx?s=bio, 12.12. Accessed at: 2017
[8] http://bvb.ro/FinancialInstruments/Details/FinancialInstrumentsDetails.aspx?s=RMAH. Accessed at: 12.12.2017
[9] http://bvb.ro/FinancialInstruments/Details/FinancialInstrumentsDetails.aspx?s=RPH. Accessed at: 12.12.2017
[10] http://bvb.ro/FinancialInstruments/Details/FinancialInstrumentsDetails.aspx?s=atb. Accessed at: 12.12.2017
[11] http://www.economica.net/antibiotice-iasi-va-creste-exporturile-in-sua-firma-vinde-de-4-ori-mai-mult-ca-in-2007_44323.html. Accessed at: 18.12.2017
[12] http://www.politicidesanatate.ro/topul-celor-mai-puternice-companii-farma-la-nivel-mondial/, 12. Accessed at: 12.2017
[13] http://www.remedia.ro/wp-content/uploads/2017/02/RMAH_RAPORT_CA_consolidat_Q3_2016_RO.pdf, 15.12 Accessed at: 2017
[14] https://bvb.ro/infocont/infocont17/RMAH_20170427180435_Raport-anual-2016-RO-Guv.pdf, accessedon 15.12.2017
[15] https://igeahub.com/2017/03/14/top-10-pharmaceutical-companies-2017/, Accessed at: 12.12.2017
Copyright (c) 2018 LUMEN Proceedings
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Selection and peer-review under responsibility of the Organizing Committee of the conference.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
© LUMEN Proceedings Series 2022 . The LUMEN Proceedings Open Access volumes are distributed under the terms of the 